Nivolumab-induced Adrenal Insufficiency in Patients With Renal Cell Carcinoma
In conclusion, we described, for the first time, a case series of nivolumab-induced adrenal insufficiency in patients with mRCC. Our findings may be useful for the accurate diagnosis and the prompt treatment of this condition. In addition, there is a possibility that adrenal insufficiency may be associated with a favorable response to nivolumab in patients with mRCC.
Source: Journal of Immunotherapy - Category: Allergy & Immunology Tags: Clinical Studies Source Type: research
More News: Addison's Disease | Adrenal Insufficiency | Allergy & Immunology | Brain | Cancer & Oncology | Carcinoma | Hormones | Hydrocortisone | Immunotherapy | Kidney Cancer | Laboratory Medicine | MRI Scan | Neurology | Renal Cell Carcinoma | Study